ArticlePloS one2015

Double Relapsed and/or Refractory Multiple Myeloma: Clinical Outcomes and Real World Healthcare Costs.

Sarah Gooding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.